Unknown

Dataset Information

Anti-inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model.


ABSTRACT:

Background

Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Sorafenib is the standard treatment used in the advanced stages of HCC. Cell therapy with mesenchymal stem cells (MSCs)-based cell therapy has proven effective in immune regulation and tumour growth inhibition.

Objectives

In this study, we investigated the anti-inflammatory effect of MSCs on HCC xenografts.

Methods

Human HepG2 cell lines were subcutaneously implanted into the flank of 12 nude mice, divided into three groups: the control group, the IV group (intravenous MSCs injection) and the local group (local MSCs injection). Mice were sacrificed 6 weeks after tumour implantation, and tumours were resected entirety. Quantitati

SUBMITTER: Hajighasemlou S 

PROVIDER: S-EPMC9514506 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature